Tauklarify (florquinitau F 18 injection) is a brain PET scan for tau tangles in adults with cognitive impairment evaluated for Alzheimer's. Blood tests screen for amyloid pathology, so a negative high-sensitivity blood result points away from Alzheimer's and any positive result needs confirmation.
Enigma Biomedical USA said in the FDA approval announcement that Tauklarify gained FDA approval for brain PET in cognitively impaired adults evaluated for Alzheimer's. The scan highlights tau neurofibrillary tangle pathology. Blood tests take a different path and look for amyloid signals in plasma.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does each test measure?
- What does a negative result mean?
- What does a positive result mean?
- What should you ask your doctor next?
What does each test measure?
Tauklarify PET uses an injected tracer and a brain scan to map tau tangles. It answers whether tau pathology is visible in regions linked to Alzheimer's. Blood tests use a blood draw to measure amyloid-related proteins such as phosphorylated tau.
Think of blood testing as a filter and tau PET as a locator. The filter flags who is unlikely to have amyloid buildup. The locator shows where tau has spread when Alzheimer's is already under evaluation.
What does a negative result mean?
A negative high-sensitivity blood test lowers the chance of amyloid pathology. Roche reported in the Labcorp press summary that its Elecsys pTau181 test showed 97.9% negative predictive value in a 312-person low-prevalence study. In a low-risk primary-care group, that pattern supports looking for other causes of memory change.
A negative tau PET also needs context. Clinical Advisor reported in its approval coverage that a positive or negative Tauklarify scan alone neither confirms nor excludes tau pathology. Ask what else could explain symptoms and whether follow-up testing is planned.
What does a positive result mean?
A positive blood test does not equal Alzheimer's. Clinical Lab Products reported on CLEAR-AD in its study coverage that nine commercial plasma p-tau217 assays vary significantly against amyloid PET. So one brand's positive can differ from another's, and specialty follow-up with PET or spinal fluid testing is often next.
A positive tau PET means tau was seen, but readers should not treat it as a standalone diagnosis. Other brain conditions can affect thinking. A dementia specialist weighs the scan with history, exams, and cognitive testing.
What should you ask your doctor next?
Bring both results to one visit and ask how they fit together. Ask whether impairment was measured with an objective test. Ask whether referral to specialty care is needed now.
Use these questions to guide that visit: Write down symptom onset, daily examples, and all medications. Bring a family member who sees your daily function. Schedule the referred test before you leave the office.
- What did my blood test rule in or rule out?
- Does my tau PET change the likely cause?
- Do I need PET, spinal fluid testing, or repeat monitoring?
- What sleep, medication, mood, or vascular factors should we address first?
You Might Also Like
- PrecivityAD2 and Younger-Onset Alzheimer’s Diagnosis in 2026: Questions Memory Clinic Patients Can Bring to a Clinician
- How 2026 Tau Imaging News May Affect Alzheimer’s Workups: Questions Memory Clinic Patients Can Bring to a Clinician
- PrecivityAD2 as an Adjunct to a 2026 Alzheimer’s Assessment: Questions Memory Clinic Patients Can Bring to a Clinician
